Research Letter: Proteome-wide Mendelian randomization identifies OLFM1 as a potential mediator of the risk effect of myxoedema on haemorrhoidal disease
View ORCID ProfileShifang Li, View ORCID ProfileMeijiao Gong
doi: https://doi.org/10.1101/2023.06.19.23291373
Shifang Li
1Laboratory of Immunology and Vaccinology, FARAH, ULiège, Liège 4000, Belgium
Meijiao Gong
1Laboratory of Immunology and Vaccinology, FARAH, ULiège, Liège 4000, Belgium
Posted June 27, 2023.
Research Letter: Proteome-wide Mendelian randomization identifies OLFM1 as a potential mediator of the risk effect of myxoedema on haemorrhoidal disease
Shifang Li, Meijiao Gong
medRxiv 2023.06.19.23291373; doi: https://doi.org/10.1101/2023.06.19.23291373
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12741)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4581)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4348)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6934)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (211)
- Urology (180)